New
research at the University of Adelaide, Australia, may help pave the way
toward the potential inhibition of multiple sclerosis (MS) and other autoimmune
diseases. The study entitled “CCR2 defines in vivo development and
homing of IL-23-driven GM-CSF-producing Th17 cells” was published in the
journal Nature Communications. In the study, researchers showed that CCR2,
a chemokine receptor, is involved […]
research at the University of Adelaide, Australia, may help pave the way
toward the potential inhibition of multiple sclerosis (MS) and other autoimmune
diseases. The study entitled “CCR2 defines in vivo development and
homing of IL-23-driven GM-CSF-producing Th17 cells” was published in the
journal Nature Communications. In the study, researchers showed that CCR2,
a chemokine receptor, is involved […]
The post Potential Multiple Sclerosis Therapy Based on CCR2 Inhibition
appeared first on Multiple Sclerosis News Today.
appeared first on Multiple Sclerosis News Today.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
MS Views and News helps to provide information for all affected by MS
Keep up to date with the news and information we provide
by signing up by clicking here
.===================================
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews
